StockNews.com initiated coverage on shares of Camden National (NASDAQ:CAC – Free Report) in a research note published on Saturday. The brokerage issued a hold rating on the financial services provider’s stock.
A number of other analysts also recently issued reports on the company. Stephens raised their price objective on Camden National from $35.00 to $42.00 and gave the stock an equal weight rating in a research report on Friday, August 2nd. Keefe, Bruyette & Woods lifted their price target on shares of Camden National from $40.00 to $41.00 and gave the company a market perform rating in a research report on Wednesday, September 11th.
View Our Latest Stock Report on CAC
Camden National Stock Performance
Camden National (NASDAQ:CAC – Get Free Report) last released its quarterly earnings data on Tuesday, July 30th. The financial services provider reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. Camden National had a return on equity of 10.36% and a net margin of 16.01%. The firm had revenue of $72.81 million for the quarter, compared to analysts’ expectations of $41.07 million. During the same period in the prior year, the firm posted $0.85 earnings per share. Analysts forecast that Camden National will post 3.34 EPS for the current year.
Hedge Funds Weigh In On Camden National
Several institutional investors have recently bought and sold shares of CAC. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Camden National in the second quarter worth $73,000. BNP Paribas Financial Markets grew its stake in Camden National by 89.3% during the 1st quarter. BNP Paribas Financial Markets now owns 7,060 shares of the financial services provider’s stock worth $237,000 after purchasing an additional 3,330 shares in the last quarter. Trexquant Investment LP purchased a new stake in Camden National during the 4th quarter worth about $294,000. Inspire Investing LLC purchased a new stake in Camden National during the 2nd quarter worth about $349,000. Finally, Price T Rowe Associates Inc. MD raised its position in Camden National by 43.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,271 shares of the financial services provider’s stock valued at $546,000 after purchasing an additional 4,907 shares in the last quarter. 77.41% of the stock is owned by institutional investors and hedge funds.
About Camden National
Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers in Maine, New Hampshire, and Massachusetts. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system.
Further Reading
- Five stocks we like better than Camden National
- Using the MarketBeat Dividend Yield Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Investing in Commodities: What Are They? How to Invest in Them
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Dividend Payout Ratio Calculator
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Camden National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Camden National and related companies with MarketBeat.com's FREE daily email newsletter.